These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Biochemical and biological analysis of Mek1 phosphorylation site mutants. Huang W; Kessler DS; Erikson RL Mol Biol Cell; 1995 Mar; 6(3):237-45. PubMed ID: 7612960 [TBL] [Abstract][Full Text] [Related]
4. MEKK1 phosphorylates MEK1 and MEK2 but does not cause activation of mitogen-activated protein kinase. Xu S; Robbins D; Frost J; Dang A; Lange-Carter C; Cobb MH Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6808-12. PubMed ID: 7624324 [TBL] [Abstract][Full Text] [Related]
5. Characterization of ERK1 activation site mutants and the effect on recognition by MEK1 and MEK2. Butch ER; Guan KL J Biol Chem; 1996 Feb; 271(8):4230-5. PubMed ID: 8626767 [TBL] [Abstract][Full Text] [Related]
6. Constitutively active mutant of the mitogen-activated protein kinase kinase MEK1 induces epithelial dedifferentiation and growth inhibition in madin-darby canine kidney-C7 cells. Schramek H; Feifel E; Healy E; Pollack V J Biol Chem; 1997 Apr; 272(17):11426-33. PubMed ID: 9111053 [TBL] [Abstract][Full Text] [Related]
7. MEK1 is required for PDGF-induced ERK activation and DNA synthesis in tracheal myocytes. Karpova AY; Abe MK; Li J; Liu PT; Rhee JM; Kuo WL; Hershenson MB Am J Physiol; 1997 Mar; 272(3 Pt 1):L558-65. PubMed ID: 9124614 [TBL] [Abstract][Full Text] [Related]
8. Properties of MEKs, the kinases that phosphorylate and activate the extracellular signal-regulated kinases. Zheng CF; Guan KL J Biol Chem; 1993 Nov; 268(32):23933-9. PubMed ID: 8226933 [TBL] [Abstract][Full Text] [Related]
9. Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins. Frost JA; Steen H; Shapiro P; Lewis T; Ahn N; Shaw PE; Cobb MH EMBO J; 1997 Nov; 16(21):6426-38. PubMed ID: 9351825 [TBL] [Abstract][Full Text] [Related]
10. The MEK1 proline-rich insert is required for efficient activation of the mitogen-activated protein kinases ERK1 and ERK2 in mammalian cells. Dang A; Frost JA; Cobb MH J Biol Chem; 1998 Jul; 273(31):19909-13. PubMed ID: 9677429 [TBL] [Abstract][Full Text] [Related]
11. Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase. Salmeron A; Ahmad TB; Carlile GW; Pappin D; Narsimhan RP; Ley SC EMBO J; 1996 Feb; 15(4):817-26. PubMed ID: 8631303 [TBL] [Abstract][Full Text] [Related]
12. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade. Lengyel E; Wang H; Gum R; Simon C; Wang Y; Boyd D Oncogene; 1997 May; 14(21):2563-73. PubMed ID: 9191056 [TBL] [Abstract][Full Text] [Related]
13. Raf-1 forms a stable complex with Mek1 and activates Mek1 by serine phosphorylation. Huang W; Alessandrini A; Crews CM; Erikson RL Proc Natl Acad Sci U S A; 1993 Dec; 90(23):10947-51. PubMed ID: 8248196 [TBL] [Abstract][Full Text] [Related]
14. Selective activation of MEK1 but not MEK2 by A-Raf from epidermal growth factor-stimulated Hela cells. Wu X; Noh SJ; Zhou G; Dixon JE; Guan KL J Biol Chem; 1996 Feb; 271(6):3265-71. PubMed ID: 8621729 [TBL] [Abstract][Full Text] [Related]
16. Inducible expression of a mutant form of MEK1 in Swiss 3T3 cells. Syu LJ; Guan KL; Saltiel AR J Cell Biochem; 1997 Dec; 67(3):367-77. PubMed ID: 9361191 [TBL] [Abstract][Full Text] [Related]
17. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Robinson MJ; Stippec SA; Goldsmith E; White MA; Cobb MH Curr Biol; 1998 Oct; 8(21):1141-50. PubMed ID: 9799732 [TBL] [Abstract][Full Text] [Related]
18. Cot protooncoprotein activates the dual specificity kinases MEK-1 and SEK-1 and induces differentiation of PC12 cells. Hagemann D; Troppmair J; Rapp UR Oncogene; 1999 Feb; 18(7):1391-400. PubMed ID: 10050876 [TBL] [Abstract][Full Text] [Related]
19. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells. Okumura K; Shirasawa S; Nishioka M; Sasazuki T Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756 [TBL] [Abstract][Full Text] [Related]